Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 4NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 5Neuroblastoma 4Ganglioneuroblastoma 4Breast Neoplasms 4Prostatic Neoplasms 3Medulloblastoma 3Wilms Tumor 2Teratoma 2Squamous Cell Carcinoma of Head and Neck 2Small Cell Lung Carcinoma 2Rhabdomyosarcoma, Embryonal 2Rhabdomyosarcoma 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 2Mouth Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Laryngeal Neoplasms 2Hypopharyngeal Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Intraductal, Noninfiltrating 2Carcinoma, Embryonal 2Carcinoma 2Burkitt Lymphoma 2Astrocytoma 2Uterine Cervical Neoplasms 1Stage I Mixed Cell Type Kidney Wilms Tumor 1Seizures 1Sarcoma, Ewing 1Rhabdomyosarcoma, Alveolar 1

Interventions

pembrolizumab 1lenvatinib 1cabozantinib 1Specimen Handling 1Pluvicto 1Nivolumab 1Magnetic Resonance Spectroscopy 1Ipilimumab 1Hyaluronoglucosaminidase 1CTLA-4 Antigen 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Clear-cell metastatic renal cell carcinoma × Magnetic Resonance Spectroscopy × Clear all
NCT07383441 2026-02-03

Adding Biotherapy or Placebo to Standard Treatment for Advanced Kidney Cancer

SWOG Cancer Research Network

Phase 3 Not yet recruiting
718 enrolled
Genitourinary

Clear-cell metastatic renal cell carcinoma, Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡